Health Affairs, 24, no. 3 (2005): 635-642 doi: 10.1377/hlthaff.24.3.635 © 2005 by Project HOPE	New Online   Pay Cuts For Medicare Docs   Access To Care Woes   Public Coverage More Efficient   Empowering Consumers

This Article Full Text (HTML) Reprint (PDF) Online Appendix Submit a response to this article Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services E-mail this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Add to My Personal Archive Download to Citation Manager Reprints & Permissions Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (7) Citing Articles via Google Scholar Google Scholar Articles by Coleman, M. S. Articles by Chu, S. Search for Related Content PubMed PubMed Citation Articles by Coleman, M. S. Articles by Chu, S. Related Collections Consumer Issues Health Promotion/Disease Prevention International Issues Vaccines Pharmaceuticals Public Health Research And Technology

Infrastructure

Factors Affecting U.S. Manufacturers’ Decisions To Produce Vaccines

Recent supply interruptions of childhood vaccines have had negative impacts on U.S. public health policies and vaccine delivery. To understand how manufacturers perceive production incentives and disincentives, the Centers for Disease Control and Prevention (CDC) met with the four pharmaceutical firms that sold vaccines through CDC-negotiated contracts during 2002 and 2003. These meetings shed light on the regulatory burden, high costs of the delay between initial investment and sales, and higher costs of new technologies versus older vaccines. All four manufacturers are investing more in research and development because new technologies have advanced their ability to create vaccines not thought possible before.

                      What's this?

This article has been cited by other articles:

				A. Kempe, M. F. Daley, U. D. Parashar, L. A. Crane, B. L. Beaty, S. Stokley, J. Barrow, C. Babbel, L. M. Dickinson, M.-A. Widdowson, et al. Will Pediatricians Adopt the New Rotavirus Vaccine? Pediatrics, January 1, 2007; 119(1): 1 - 10. [Abstract] [Full Text] [PDF]

				M. M. Mello and T. A. Brennan Legal Concerns and the Influenza Vaccine Shortage JAMA, October 12, 2005; 294(14): 1817 - 1820. [Full Text] [PDF]